Dr Stephen Minger, Global Head of Research and Development, Cell Technologies, GE Healthcare Life Sciences was honored by Federation of Asian Biotech Associations (FABA) with a Special Award for his out-standing contributions in the field of stem cells. The FABA Special Award was handed over by Dr A.P.J. Abdul Kalam, former President of India, during the International Conference on Stem Cell and Regenerative Medicine recently held in Hyderabad, India.
The FABA Special Award is presented to outstanding scientists who have made significant contributions in the field of bio-technology. Dr Stephen Minger was chosen as a recipient of FABA Special Award 2012 for his out-standing contributions in the field of stem cells including teaching, research and advocacy.
GE Healthcare has an active stem cell research program under the direction of Dr Minger. In December 2011 the company announced a pioneering research project with the University of California San Francisco aimed at making better use of cord blood donations. In 2010 the company launched Cytivaâ¢ cardiomyocytes (human heart cells), stem cell-based assays that are already helping pharmaceutical companies develop safer medicines by identifying much earlier in the discovery process drug candidates that show toxic effects. Also under development are cell-handling and processing technologies that will help enable the new era of regenerative medicine and cell therapy.